Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31157963

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Jul 25
First author
Golan T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Aug;9(8):OF6. doi: 10.1158/2159-8290.CD-NB2019-065.
    note
    Source null
    related pmid
    31164341
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2019 Oct;16(10):595-596. doi: 10.1038/s41571-019-0257-6.
    note
    Source null
    related pmid
    31332344
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Oct 10;381(15):1491. doi: 10.1056/NEJMc1911185.
    note
    Source null
    related pmid
    31597027
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Oct 10;381(15):1491-1492. doi: 10.1056/NEJMc1911185.
    note
    Source null
    related pmid
    31597028
    relationship
    Comment in
  5. citation
    Transl Cancer Res. 2020 Apr;9(4):2154-2156. doi: 10.21037/tcr.2020.03.07.
    note
    Source null
    related pmid
    35117572
    relationship
    Comment in
  6. citation
    Transl Cancer Res. 2020 Apr;9(4):2157-2160. doi: 10.21037/tcr.2020.02.75.
    note
    Source null
    related pmid
    35117573
    relationship
    Comment in

Authors and identifiers

  1. name
    Golan T
    type
    Author
  2. name
    Hammel P
    type
    Author
  3. name
    Reni M
    type
    Author
  4. name
    Van Cutsem E
    type
    Author
  5. name
    Macarulla T
    type
    Author
  6. name
    Hall MJ
    type
    Author
  7. name
    Park JO
    type
    Author
  8. name
    Hochhauser D
    type
    Author
  9. name
    Arnold D
    type
    Author
  10. name
    Oh DY
    type
    Author
  11. name
    Reinacher-Schick A
    type
    Author
  12. name
    Tortora G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Golan T
    type
    Author
  2. name
    Hammel P
    type
    Author
  3. name
    Reni M
    type
    Author
  4. name
    Van Cutsem E
    type
    Author
  5. name
    Macarulla T
    type
    Author
  6. name
    Hall MJ
    type
    Author
  7. name
    Park JO
    type
    Author
  8. name
    Hochhauser D
    type
    Author
  9. name
    Arnold D
    type
    Author
  10. name
    Oh DY
    type
    Author
  11. name
    Reinacher-Schick A
    type
    Author
  12. name
    Tortora G
    type
    Author
bibliography ids
  1. nci-bib-2e8493c186c917d0fb2bfebe
book metadata
content sha256
43ebb885259450035dd9f2e8a5d58f43b702936eb3e9c03030425592ebacfc1e
document type
citation
dois
  1. 10.1056/NEJMoa1903387
electronic publication date
display
2019 Jun 2
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31157963
immutable id
pubmed:31157963@43ebb885259450035dd9f2e8a5d58f43b702936eb3e9c03030425592ebacfc1e
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
317-327
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Aug;9(8):OF6. doi: 10.1158/2159-8290.CD-NB2019-065.
    note
    Source null
    related pmid
    31164341
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2019 Oct;16(10):595-596. doi: 10.1038/s41571-019-0257-6.
    note
    Source null
    related pmid
    31332344
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Oct 10;381(15):1491. doi: 10.1056/NEJMc1911185.
    note
    Source null
    related pmid
    31597027
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Oct 10;381(15):1491-1492. doi: 10.1056/NEJMc1911185.
    note
    Source null
    related pmid
    31597028
    relationship
    Comment in
  5. citation
    Transl Cancer Res. 2020 Apr;9(4):2154-2156. doi: 10.21037/tcr.2020.03.07.
    note
    Source null
    related pmid
    35117572
    relationship
    Comment in
  6. citation
    Transl Cancer Res. 2020 Apr;9(4):2157-2160. doi: 10.21037/tcr.2020.02.75.
    note
    Source null
    related pmid
    35117573
    relationship
    Comment in
outcomes validated
false
pmid
31157963
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
50c921fa9c2950a755db68eea053294a1c3717e6bffaf6b030c8a60cf1255dc6
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Jul 25
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31157963/
title
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Preserved source evidence · Not medical advice